Parkinsons Disease Treatments Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dopamine Agonists
1.2.3 Levodopa
1.2.4 Glutamate Antagonist
1.2.5 Apomorphine
1.2.6 COMT Inhibitors Anticholinergics
1.2.7 MAO-B Inhibitors
1.2.8 Other Drugs
1.3 Market by Application
1.3.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Healthcare Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Treatments Market Perspective (2017-2028)
2.2 Parkinson's Disease Treatments Growth Trends by Region
2.2.1 Parkinson's Disease Treatments Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Parkinson's Disease Treatments Historic Market Size by Region (2017-2022)
2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Region (2023-2028)
2.3 Parkinson's Disease Treatments Market Dynamics
2.3.1 Parkinson's Disease Treatments Industry Trends
2.3.2 Parkinson's Disease Treatments Market Drivers
2.3.3 Parkinson's Disease Treatments Market Challenges
2.3.4 Parkinson's Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Treatments Players by Revenue
3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2017-2022)
3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2017-2022)
3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue
3.4 Global Parkinson's Disease Treatments Market Concentration Ratio
3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2021
3.5 Parkinson's Disease Treatments Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Treatments Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Treatments Breakdown Data by Type
4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2017-2022)
4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2023-2028)
5 Parkinson's Disease Treatments Breakdown Data by Application
5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2017-2022)
5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Parkinson's Disease Treatments Market Size (2017-2028)
6.2 North America Parkinson's Disease Treatments Market Size by Type
6.2.1 North America Parkinson's Disease Treatments Market Size by Type (2017-2022)
6.2.2 North America Parkinson's Disease Treatments Market Size by Type (2023-2028)
6.2.3 North America Parkinson's Disease Treatments Market Share by Type (2017-2028)
6.3 North America Parkinson's Disease Treatments Market Size by Application
6.3.1 North America Parkinson's Disease Treatments Market Size by Application (2017-2022)
6.3.2 North America Parkinson's Disease Treatments Market Size by Application (2023-2028)
6.3.3 North America Parkinson's Disease Treatments Market Share by Application (2017-2028)
6.4 North America Parkinson's Disease Treatments Market Size by Country
6.4.1 North America Parkinson's Disease Treatments Market Size by Country (2017-2022)
6.4.2 North America Parkinson's Disease Treatments Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Parkinson's Disease Treatments Market Size (2017-2028)
7.2 Europe Parkinson's Disease Treatments Market Size by Type
7.2.1 Europe Parkinson's Disease Treatments Market Size by Type (2017-2022)
7.2.2 Europe Parkinson's Disease Treatments Market Size by Type (2023-2028)
7.2.3 Europe Parkinson's Disease Treatments Market Share by Type (2017-2028)
7.3 Europe Parkinson's Disease Treatments Market Size by Application
7.3.1 Europe Parkinson's Disease Treatments Market Size by Application (2017-2022)
7.3.2 Europe Parkinson's Disease Treatments Market Size by Application (2023-2028)
7.3.3 Europe Parkinson's Disease Treatments Market Share by Application (2017-2028)
7.4 Europe Parkinson's Disease Treatments Market Size by Country
7.4.1 Europe Parkinson's Disease Treatments Market Size by Country (2017-2022)
7.4.2 Europe Parkinson's Disease Treatments Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Treatments Market Size (2017-2028)
8.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type
8.2.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Parkinson's Disease Treatments Market Share by Type (2017-2028)
8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Application
8.3.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Parkinson's Disease Treatments Market Share by Application (2017-2028)
8.4 Asia-Pacific Parkinson's Disease Treatments Market Size by Region
8.4.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Treatments Market Size (2017-2028)
9.2 Latin America Parkinson's Disease Treatments Market Size by Type
9.2.1 Latin America Parkinson's Disease Treatments Market Size by Type (2017-2022)
9.2.2 Latin America Parkinson's Disease Treatments Market Size by Type (2023-2028)
9.2.3 Latin America Parkinson's Disease Treatments Market Share by Type (2017-2028)
9.3 Latin America Parkinson's Disease Treatments Market Size by Application
9.3.1 Latin America Parkinson's Disease Treatments Market Size by Application (2017-2022)
9.3.2 Latin America Parkinson's Disease Treatments Market Size by Application (2023-2028)
9.3.3 Latin America Parkinson's Disease Treatments Market Share by Application (2017-2028)
9.4 Latin America Parkinson's Disease Treatments Market Size by Country
9.4.1 Latin America Parkinson's Disease Treatments Market Size by Country (2017-2022)
9.4.2 Latin America Parkinson's Disease Treatments Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Treatments Market Size (2017-2028)
10.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type
10.2.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Parkinson's Disease Treatments Market Share by Type (2017-2028)
10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application
10.3.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Parkinson's Disease Treatments Market Share by Application (2017-2028)
10.4 Middle East & Africa Parkinson's Disease Treatments Market Size by Country
10.4.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson's Disease Treatments Introduction
11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Parkinson's Disease Treatments Introduction
11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Parkinson's Disease Treatments Introduction
11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Parkinson's Disease Treatments Introduction
11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.4.5 Teva Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Impax
11.6.1 Impax Company Details
11.6.2 Impax Business Overview
11.6.3 Impax Parkinson's Disease Treatments Introduction
11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.6.5 Impax Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Treatments Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.7.5 Abbvie Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Details
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Parkinson's Disease Treatments Introduction
11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.8.5 Bausch Health Recent Developments
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Parkinson's Disease Treatments Introduction
11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.9.5 Lundbeck Recent Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction
11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.10.5 Sun Pharma Recent Developments
11.11 Wockhardt
11.11.1 Wockhardt Company Details
11.11.2 Wockhardt Business Overview
11.11.3 Wockhardt Parkinson's Disease Treatments Introduction
11.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.11.5 Wockhardt Recent Developments
11.12 Acadia
11.12.1 Acadia Company Details
11.12.2 Acadia Business Overview
11.12.3 Acadia Parkinson's Disease Treatments Introduction
11.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.12.5 Acadia Recent Developments
11.13 UCB
11.13.1 UCB Company Details
11.13.2 UCB Business Overview
11.13.3 UCB Parkinson's Disease Treatments Introduction
11.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.13.5 UCB Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease Treatments Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Dopamine Agonists
Table 3. Key Players of Levodopa
Table 4. Key Players of Glutamate Antagonist
Table 5. Key Players of Apomorphine
Table 6. Key Players of COMT Inhibitors Anticholinergics
Table 7. Key Players of MAO-B Inhibitors
Table 8. Key Players of Other Drugs
Table 9. Global Parkinson's Disease Treatments Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Parkinson's Disease Treatments Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Parkinson's Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Parkinson's Disease Treatments Market Share by Region (2017-2022)
Table 13. Global Parkinson's Disease Treatments Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Parkinson's Disease Treatments Market Share by Region (2023-2028)
Table 15. Parkinson's Disease Treatments Market Trends
Table 16. Parkinson's Disease Treatments Market Drivers
Table 17. Parkinson's Disease Treatments Market Challenges
Table 18. Parkinson's Disease Treatments Market Restraints
Table 19. Global Parkinson's Disease Treatments Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Parkinson's Disease Treatments Revenue Share by Players (2017-2022)
Table 21. Global Top Parkinson's Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2021)
Table 22. Ranking of Global Top Parkinson's Disease Treatments Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Parkinson's Disease Treatments Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Parkinson's Disease Treatments Product Solution and Service
Table 26. Date of Enter into Parkinson's Disease Treatments Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Parkinson's Disease Treatments Revenue Market Share by Type (2017-2022)
Table 30. Global Parkinson's Disease Treatments Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Parkinson's Disease Treatments Revenue Market Share by Type (2023-2028)
Table 32. Global Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Parkinson's Disease Treatments Revenue Share by Application (2017-2022)
Table 34. Global Parkinson's Disease Treatments Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Parkinson's Disease Treatments Revenue Share by Application (2023-2028)
Table 36. North America Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Parkinson's Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Parkinson's Disease Treatments Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Parkinson's Disease Treatments Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Parkinson's Disease Treatments Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Parkinson's Disease Treatments Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Parkinson's Disease Treatments Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Parkinson's Disease Treatments Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Parkinson's Disease Treatments Market Size by Country (2023-2028) & (US$ Million)
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Parkinson's Disease Treatments Product
Table 69. GSK Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 70. GSK Recent Developments
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Parkinson's Disease Treatments Product
Table 74. Merck Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 75. Merck Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Parkinson's Disease Treatments Product
Table 79. Novartis Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Teva Company Details
Table 82. Teva Business Overview
Table 83. Teva Parkinson's Disease Treatments Product
Table 84. Teva Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 85. Teva Recent Developments
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Parkinson's Disease Treatments Product
Table 89. Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Impax Company Details
Table 92. Impax Business Overview
Table 93. Impax Parkinson's Disease Treatments Product
Table 94. Impax Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 95. Impax Recent Developments
Table 96. Abbvie Company Details
Table 97. Abbvie Business Overview
Table 98. Abbvie Parkinson's Disease Treatments Product
Table 99. Abbvie Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 100. Abbvie Recent Developments
Table 101. Bausch Health Company Details
Table 102. Bausch Health Business Overview
Table 103. Bausch Health Parkinson's Disease Treatments Product
Table 104. Bausch Health Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 105. Bausch Health Recent Developments
Table 106. Lundbeck Company Details
Table 107. Lundbeck Business Overview
Table 108. Lundbeck Parkinson's Disease Treatments Product
Table 109. Lundbeck Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 110. Lundbeck Recent Developments
Table 111. Sun Pharma Company Details
Table 112. Sun Pharma Business Overview
Table 113. Sun Pharma Parkinson's Disease Treatments Product
Table 114. Sun Pharma Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 115. Sun Pharma Recent Developments
Table 116. Wockhardt Company Details
Table 117. Wockhardt Business Overview
Table 118. Wockhardt Parkinson's Disease Treatments Product
Table 119. Wockhardt Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 120. Wockhardt Recent Developments
Table 121. Acadia Company Details
Table 122. Acadia Business Overview
Table 123. Acadia Parkinson's Disease Treatments Product
Table 124. Acadia Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 125. Acadia Recent Developments
Table 126. UCB Company Details
Table 127. UCB Business Overview
Table 128. UCB Parkinson's Disease Treatments Product
Table 129. UCB Revenue in Parkinson's Disease Treatments Business (2017-2022) & (US$ Million)
Table 130. UCB Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Treatments Market Share by Type: 2021 VS 2028
Figure 2. Dopamine Agonists Features
Figure 3. Levodopa Features
Figure 4. Glutamate Antagonist Features
Figure 5. Apomorphine Features
Figure 6. COMT Inhibitors Anticholinergics Features
Figure 7. MAO-B Inhibitors Features
Figure 8. Other Drugs Features
Figure 9. Global Parkinson's Disease Treatments Market Share by Application: 2021 VS 2028
Figure 10. Hospitals Case Studies
Figure 11. Healthcare Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Parkinson's Disease Treatments Report Years Considered
Figure 14. Global Parkinson's Disease Treatments Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Parkinson's Disease Treatments Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Parkinson's Disease Treatments Market Share by Region: 2021 VS 2028
Figure 17. Global Parkinson's Disease Treatments Market Share by Players in 2021
Figure 18. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatments Revenue in 2021
Figure 20. North America Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
Figure 22. North America Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
Figure 23. North America Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
Figure 24. United States Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
Figure 28. Europe Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
Figure 29. Europe Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
Figure 30. Germany Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Parkinson's Disease Treatments Market Size Share by Region (2017-2028)
Figure 40. China Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
Figure 50. Mexico Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Parkinson's Disease Treatments Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Parkinson's Disease Treatments Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Parkinson's Disease Treatments Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Parkinson's Disease Treatments Market Size Share by Country (2017-2028)
Figure 56. Turkey Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Parkinson's Disease Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 62. Teva Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 64. Impax Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 65. Abbvie Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 66. Bausch Health Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 67. Lundbeck Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 68. Sun Pharma Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 69. Wockhardt Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 70. Acadia Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 71. UCB Revenue Growth Rate in Parkinson's Disease Treatments Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
